Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • MiSeq competition?

    Hi,

    Just doing a little essay on desktop NGS tech and was wondering if anyone could help me out.

    As I understand, the consensus is on the MiSeq system generally for higher throughput and accuracy (homopolymers and indels - still the case?) as compared to the Ion PGM, as well as ease of preparation. With the Ion PGM being the better choice if you have varying amount of samples that need quicker turnaround. With costs essentially the same when it comes down to usable data.

    My questions are two-fold: Does this still apply in terms of RNA-seq specifically? And now with the S5, does this change it at all? Or is it just an ease of use improvement.

    Also, is there any other desktop NGS system that competes in this space currently available?

    Thanks

  • #2
    Well, there's the MiniSeq, which is a bit smaller, a bit cheaper (capital cost), and a bit faster, but not really all that useful for people who already have a MiSeq. There's even a competition going for it at the moment:

    Winning laboratories to use next-generation sequencing for entomology, virology, and oncology research


    And, of course, MinION, which currently has an output in the hundreds of megabases for a reasonable flow cell. It's possible Sequel might compete in the low-end high-throughput space as well, depending on how much you are prepared to put down for the sequencer.
    Last edited by gringer; 02-10-2016, 07:53 PM.

    Comment

    Latest Articles

    Collapse

    • seqadmin
      Understanding Genetic Influence on Infectious Disease
      by seqadmin




      During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

      Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
      09-09-2024, 10:59 AM
    • seqadmin
      Addressing Off-Target Effects in CRISPR Technologies
      by seqadmin






      The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
      08-27-2024, 04:44 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by seqadmin, Today, 06:25 AM
    0 responses
    13 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, Yesterday, 01:02 PM
    0 responses
    12 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 09-18-2024, 06:39 AM
    0 responses
    14 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 09-11-2024, 02:44 PM
    0 responses
    14 views
    0 likes
    Last Post seqadmin  
    Working...
    X